Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis

Oscar Cirioni, Oriana Simonetti, Gianluca Morroni, Lucia Brescini, Wojciech Kamysz, Elzbieta Kamysz, Fiorenza Orlando, Elisa Pierpaoli, Miriam Caffarini, Monia Orciani, Claudio Agostinelli, Annamaria Offidani, Mauro Provinciali, Andrea Giacometti

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Pseudomonas aeruginosa is a gram-negative pathogen, associated with a severe mortality rate. It is also difficult to treat due to numerous resistance mechanisms to a wide range of antibiotics.

OBJECTIVE: Evaluate the activity of pexiganan, an antimicrobial peptide, in combination with two clinical antibiotics (azithromycin and tigecycline) that are not active against P. aeruginosa.

METHODS: Ten clinical P. aeruginosa were isolated from urinary tract infections, blood culture, skin infections and respiratory tract infections. Minimum inhibitory concentrations (MICs) and synergies were evaluated by broth microdilution, checkerboard assays and time-kill studies. In vitro synergy was confirmed with an in vivo experiment using a murine model of sepsis.

RESULTS: Pexiganan MICs were included between 2 and 16 mg/L. Tigecycline and azithromycin MICs were high as expected (4-64 mg/L and 32-256 mg/L, respectively). Pexiganan and azithromycin combination resulted to be additive or indifferent while tigecycline and pexiganan combination was synergic against seven out of ten P. aeruginosa and additive against the other strains. In vivo experiment confirmed the in vitro synergy, denoting a significative reduction of bacteria in mice treated with pexiganan and tigecycline combination.

CONCLUSION: Antimicrobial peptides are molecules that could be useful in the fight against infections and pexiganan seems to be one of the most promising. Our results demonstrated that, in association with tigecycline, pexiganan administration could overcome antibiotic resistance and increase the effectiveness of treatment against P. aeruginosa sepsis.

Original languageEnglish
Pages (from-to)2127-2132
Number of pages6
JournalCurrent Topics in Medicinal Chemistry
Volume18
Issue number24
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis'. Together they form a unique fingerprint.

  • Cite this

    Cirioni, O., Simonetti, O., Morroni, G., Brescini, L., Kamysz, W., Kamysz, E., Orlando, F., Pierpaoli, E., Caffarini, M., Orciani, M., Agostinelli, C., Offidani, A., Provinciali, M., & Giacometti, A. (2018). Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis. Current Topics in Medicinal Chemistry, 18(24), 2127-2132. https://doi.org/10.2174/1568026619666181219123431